U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211438) titled 'Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression' on Oct. 02.
Brief Summary: Psilocybin, the chemical component of "magic mushrooms", has been administered with psychological support in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects.
The purpose of this study is to determine the role of psilocybin monitors on the effects of psilocybin therapy in adults with treatment resistant depression.
Study Start Date: April 01, 2026
Study Type: INTERVENTIONAL
Condition:
Treatment-Resistant Depression
Intervention:
DRUG: Psilocybin
25 mg Psilo...